Third-generation smallpox vaccines: challenges in the absence of clinical smallpox.
about
Cytokine production associated with smallpox vaccine responsesEffect of the deletion of genes encoding proteins of the extracellular virion form of vaccinia virus on vaccine immunogenicity and protective effectiveness in the mouse model.Passive immunotherapies protect WRvFire and IHD-J-Luc vaccinia virus-infected mice from lethality by reducing viral loads in the upper respiratory tract and internal organs
P2860
Third-generation smallpox vaccines: challenges in the absence of clinical smallpox.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Third-generation smallpox vaccines: challenges in the absence of clinical smallpox.
@en
Third-generation smallpox vaccines: challenges in the absence of clinical smallpox.
@nl
type
label
Third-generation smallpox vaccines: challenges in the absence of clinical smallpox.
@en
Third-generation smallpox vaccines: challenges in the absence of clinical smallpox.
@nl
prefLabel
Third-generation smallpox vaccines: challenges in the absence of clinical smallpox.
@en
Third-generation smallpox vaccines: challenges in the absence of clinical smallpox.
@nl
P2860
P356
P1433
P1476
Third-generation smallpox vaccines: challenges in the absence of clinical smallpox.
@en
P2093
Clement A Meseda
Jerry P Weir
P2860
P304
P356
10.2217/FMB.10.98
P577
2010-09-01T00:00:00Z